Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Extracorporeal Life Support and New Therapeutic Strategies for Cardiac Arrest Caused by Acute Myocardial Infarction - a Critical Approach for a Critical Condition.

Benedek T, Popovici MM, Glogar D.

J Crit Care Med (Targu Mures). 2016 Nov 8;2(4):164-174. doi: 10.1515/jccm-2016-0025. eCollection 2016 Oct.

2.

Valvuloplasty with a paclitaxel-eluting balloon prevents restenosis in an experimental animal model of aortic stenosis.

Spargias K, Gyöngyösi M, Hemetsberger R, Posa A, Pavo N, Pavo IJ, Huber K, Petrasi Z, Petnehazy O, von Strandmann RP, Park J, Glogar D, Maurer G, Rajamannan NM.

J Heart Valve Dis. 2014 Jul;23(4):484-91.

PMID:
25803975
3.

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.

Krenn L, Kopp C, Glogar D, Lang IM, Delle-Karth G, Neunteufl T, Kreiner G, Kaider A, Bergler-Klein J, Khorsand A, Nikfardjam M, Laufer G, Maurer G, Gyöngyösi M.

Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1029-39. doi: 10.1002/ccd.25397. Epub 2014 Feb 1.

4.

Comparison of short- and long-term results of drug-eluting vs. bare metal stenting in the porcine internal carotid artery.

Schwarzmaier-D'Assie A, Nyolczas N, Hemetsberger R, Strehblow C, Matiasek J, Farhan S, Petrasi Z, Huber K, Wojta J, Glogar D, Plass C, Gyöngyösi M, Karnik R.

J Endovasc Ther. 2011 Aug;18(4):547-58. doi: 10.1583/10-3347.1.

PMID:
21861747
5.

High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis.

Katsaros KM, Wiesbauer F, Speidl WS, Kastl SP, Huber K, Zorn G, Niessner A, Glogar D, Maurer G, Wojta J.

Thromb Haemost. 2011 May;105(5):883-91. doi: 10.1160/TH10-09-0566. Epub 2011 Feb 28.

PMID:
21359408
6.

A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial.

Kastrup J, Jørgensen E, Fuchs S, Nikol S, Bøtker HE, Gyöngyösi M, Glogar D, Kornowski R.

EuroIntervention. 2011 Feb;6(7):813-8. doi: 10.4244/EIJV6I7A140.

PMID:
21252014
7.

Drug-eluting introducer sheath prevents local peripheral complications: pre-clinical evaluation of nitric oxide-coated sheath.

Hemetsberger R, Posa A, Farhan S, Hemetsberger H, Redwan B, Pavo N, Pavo IJ, Plass CA, Petnehazy O, Petrasi Z, Huber K, Glogar D, Maurer G, Gyöngyösi M.

JACC Cardiovasc Interv. 2011 Jan;4(1):98-106. doi: 10.1016/j.jcin.2010.09.018.

8.

Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.

van der Schaaf RJ, Claessen BE, Hoebers LP, Verouden NJ, Koolen JJ, Suttorp MJ, Barbato E, Bax M, Strauss BH, Olivecrona GK, Tuseth V, Glogar D, Råmunddal T, Tijssen JG, Piek JJ, Henriques JP; EXPLORE investigators.

Trials. 2010 Sep 21;11:89. doi: 10.1186/1745-6215-11-89.

9.

Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion.

Gyöngyösi M, Posa A, Pavo N, Hemetsberger R, Kvakan H, Steiner-Böker S, Petrási Z, Manczur F, Pavo IJ, Edes IF, Wojta J, Glogar D, Huber K.

Thromb Haemost. 2010 Aug;104(2):376-84. doi: 10.1160/TH09-08-0558. Epub 2010 Mar 29.

PMID:
20352158
10.

Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study.

Charwat S, Lang I, Dettke M, Graf S, Nyolczas N, Hemetsberger R, Zamini S, Khorsand A, Sochor H, Maurer G, Glogar D, Gyöngyösi M.

Thromb Haemost. 2010 Mar;103(3):564-71. doi: 10.1160/TH09-08-0520. Epub 2010 Jan 13.

PMID:
20076851
11.

Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression.

Gyöngyösi M, Blanco J, Marian T, Trón L, Petneházy O, Petrasi Z, Hemetsberger R, Rodriguez J, Font G, Pavo IJ, Kertész I, Balkay L, Pavo N, Posa A, Emri M, Galuska L, Kraitchman DL, Wojta J, Huber K, Glogar D.

Circ Cardiovasc Imaging. 2008 Sep;1(2):94-103. doi: 10.1161/CIRCIMAGING.108.797449. Epub 2008 Jul 30.

12.

2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.

Gyöngyösi M, Christ G, Lang I, Kreiner G, Sochor H, Probst P, Neunteufl T, Badr-Eslam R, Winkler S, Nyolczas N, Posa A, Leisch F, Karnik R, Siostrzonek P, Harb S, Heigert M, Zenker G, Benzer W, Bonner G, Kaider A, Glogar D; AUTAX Investigators.

JACC Cardiovasc Interv. 2009 Aug;2(8):718-27. doi: 10.1016/j.jcin.2009.05.019.

13.

Tracking the migration of cardially delivered therapeutic stem cells in vivo: state of the art.

Nyolczas N, Charwat S, Posa A, Hemetsberger R, Pavo N, Hemetsberger H, Pavo IJ, Glogar D, Maurer G, Gyöngyösi M.

Regen Med. 2009 May;4(3):407-22. doi: 10.2217/rme.09.14. Review.

PMID:
19438316
15.

Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition.

Sarno G, Lerman A, Bae JH, Schukro C, Glogar D, Margolis PM, Goethals M, Verstreken S, Bartunek J, Koenig A, Wijns W, Vanderheyden M.

Nat Clin Pract Cardiovasc Med. 2009 Jan;6(1):61-9. doi: 10.1038/ncpcardio1410. Epub 2008 Dec 2.

PMID:
19047995
16.

Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries.

Hemetsberger R, Farhan S, Strehblow C, Sperker W, Pavo I, Petrasi Z, Hemetsberger H, Posa A, Huber K, Glogar D, Gyöngyösi M.

Coron Artery Dis. 2008 Dec;19(8):635-43. doi: 10.1097/MCA.0b013e32831425ed.

PMID:
19005299
17.

Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study.

Gyöngyösi M, Lang I, Dettke M, Beran G, Graf S, Sochor H, Nyolczas N, Charwat S, Hemetsberger R, Christ G, Edes I, Balogh L, Krause KT, Jaquet K, Kuck KH, Benedek I, Hintea T, Kiss R, Préda I, Kotevski V, Pejkov H, Zamini S, Khorsand A, Sodeck G, Kaider A, Maurer G, Glogar D.

Nat Clin Pract Cardiovasc Med. 2009 Jan;6(1):70-81. doi: 10.1038/ncpcardio1388. Epub 2008 Nov 11.

PMID:
19002124
18.

Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.

Katsaros KM, Kastl SP, Huber K, Zorn G, Maurer G, Glogar D, Wojta J, Christ G, Speidl WS.

Thromb Res. 2008;123(1):79-84. doi: 10.1016/j.thromres.2008.04.017. Epub 2008 Jun 16.

PMID:
18558425
19.

Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting model.

Farhan S, Hemetsberger R, Matiasek J, Strehblow C, Pavo N, Khorsand A, Petneházy O, Petrási Z, Kaider A, Glogar D, Huber K, Gyöngyösi M.

Atherosclerosis. 2009 Jan;202(1):144-51. doi: 10.1016/j.atherosclerosis.2008.04.039. Epub 2008 Apr 29.

PMID:
18514201
20.

Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries.

Posa A, Hemetsberger R, Petnehazy O, Petrasi Z, Testor M, Glogar D, Gyöngyösi M.

Coron Artery Dis. 2008 Jun;19(4):243-7. doi: 10.1097/MCA.0b013e3283030b26.

PMID:
18480668
21.

Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation.

Wexberg P, Jordanova N, Strehblow C, Syeda B, Meyer B, Charvat S, Zorn G, Scheinig D, Wojta J, Huber K, Glogar D, Gyöngyösi M.

Thromb Haemost. 2008 Apr;99(4):739-48. doi: 10.1160/TH07-05-0365.

PMID:
18392332
22.

Myocardial protection via the coronary sinus.

Mohl W, Komamura K, Kasahara H, Heinze G, Glogar D, Hirayama A, Kodama K.

Circ J. 2008 Apr;72(4):526-33.

23.

Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art.

Charwat S, Gyöngyösi M, Lang I, Graf S, Beran G, Hemetsberger R, Nyolczas N, Sochor H, Glogar D.

Exp Hematol. 2008 Jun;36(6):672-80. doi: 10.1016/j.exphem.2008.01.005. Epub 2008 Mar 20. Review.

PMID:
18358589
24.

Detection of high-grade stenoses with multislice computed tomography in heart transplant patients.

Pichler P, Loewe C, Roedler S, Syeda B, Stadler A, Aliabadi A, Schukro C, Wolf F, Zuckermann A, Lammer J, Sochor H, Glogar D.

J Heart Lung Transplant. 2008 Mar;27(3):310-6. doi: 10.1016/j.healun.2007.11.577.

PMID:
18342754
25.

Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents.

Katsaros KM, Speidl WS, Kastl SP, Zorn G, Huber K, Maurer G, Glogar D, Wojta J, Christ G.

J Thromb Haemost. 2008 Mar;6(3):508-13. doi: 10.1111/j.1538-7836.2007.02884.x. Epub 2007 Dec 25.

26.

Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients.

Schukro C, Syeda B, Yahya N, Gessl A, Holy EW, Pichler P, Derntl M, Glogar D.

J Diabetes Complications. 2007 Nov-Dec;21(6):381-6.

PMID:
17967711
27.

Duration of development of symptomatic in-stent restenosis correlates with the stent-to-vessel-diameter ratio: an intravascular ultrasound study.

Schukro C, Gruska M, Syeda B, Winkler M, Poradek T, Sipötz H, Glogar D, Gaul G.

Coron Artery Dis. 2007 Nov;18(7):507-12.

PMID:
17925602
28.

Transapical minimally invasive aortic valve implantation: multicenter experience.

Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, Doss M, Borger MA, Schuler G, Glogar D, Fehske W, Wolner E, Mohr FW, Mack M.

Circulation. 2007 Sep 11;116(11 Suppl):I240-5.

PMID:
17846311
29.

Small vessel stenting with cobalt-chromium stents (Arthos Pico) in a real world setting.

Strehblow C, Gyöngyösi M, Zenker G, Wallner H, Heigert M, Siostrzonek P, Tischler R, Probst P, Lang I, Sochor H, Glogar D.

Coron Artery Dis. 2007 Jun;18(4):305-11.

PMID:
17496495
30.

Active endothelin is an important vasoconstrictor in acute coronary thrombi.

Adlbrecht C, Bonderman D, Plass C, Jakowitsch J, Beran G, Sperker W, Siostrzonek P, Glogar D, Maurer G, Lang IM.

Thromb Haemost. 2007 Apr;97(4):642-9.

PMID:
17393028
31.

Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort.

Szük T, Gyöngyösi M, Homorodi N, Kristóf E, Király C, Edes IF, Facskó A, Pavo N, Sodeck G, Strehblow C, Farhan S, Maurer G, Glogar D, Domanovits H, Huber K, Edes I.

Am Heart J. 2007 Feb;153(2):289-95.

PMID:
17239691
32.

Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.

Nyolczas N, Gyöngyösi M, Beran G, Dettke M, Graf S, Sochor H, Christ G, Edes I, Balogh L, Krause KT, Jaquet K, Kuck KH, Benedek I, Hintea T, Kiss R, Préda I, Kotevski V, Pejkov H, Dudek D, Heba G, Sylven C, Charwat S, Jacob R, Maurer G, Lang I, Glogar D.

Am Heart J. 2007 Feb;153(2):212.e1-7.

PMID:
17239678
33.

Do long term effects after PICSO endorse the potential of cardiac regeneration after acute myocardial infarction?

Kasahara H, Komamura K, Glogar D, Kodama K, Hirayama A, Mohl W.

Wien Klin Wochenschr. 2007;119(11-12 Suppl 1):23-6. No abstract available.

PMID:
19618595
34.

Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.

Schukro C, Syeda B, Kirisits C, Schmid R, Pichler P, Pokrajac B, Lang I, Pötter R, Glogar D.

Radiother Oncol. 2007 Jan;82(1):18-23. Epub 2006 Sep 12.

PMID:
16971011
35.

Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours.

Gyöngyösi M, Strehblow C, Sperker W, Hevesi A, Garamvölgyi R, Petrási Z, Pavo N, Ferdinandy P, Csonka C, Csont T, Sylvèn C, Declerck PJ, Pavo I Jr, Wojta J, Glogar D, Huber K.

Thromb Haemost. 2006 Aug;96(2):202-9.

PMID:
16894465
36.

First in-human randomized comparison of an anodized niobium stent versus a standard stainless steel stent--an intravascular ultrasound and angiographic two-center study: the VELA study.

Beier F, Gyöngyösi M, Raeder T, von Eckardstein-Thumb E, Sperker W, Albrecht P, Spes C, Glogar D, Mudra H.

Clin Res Cardiol. 2006 Sep;95(9):455-60. Epub 2006 Jul 3.

PMID:
16799877
37.

Paradoxical effects of aurintricarboxylic acid and RG-13577: acute thrombosis and in-stent stenosis in a passive-coated stent.

Strehblow C, Sperker W, Hevesi A, Garamvölgyi R, Petrasi Z, Shirazi M, Sylvén C, Weiss T, Lotan C, Pugatsch T, Ben-Sasson SA, Orlowski M, Glogar D, Gyöngyösi M.

J Endovasc Ther. 2006 Feb;13(1):94-103.

PMID:
16445329
38.

Clinical and angiographic analysis with a cobalt alloy coronary stent (driver) in stable and unstable angina pectoris.

Legrand V, Kelbaek H, Hauptmann KE, Glogar D, Rutsch W, Grollier G, Vermeersch P, Elias J, De Cock CC; CLASS Investigators.

Am J Cardiol. 2006 Feb 1;97(3):349-52.

39.

Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients.

Syeda B, Schukro C, Kirisits C, Lang I, Siostrzonek P, Gottsauner-Wolf M, Pokrajac B, Schmid R, Yahya N, Pötter R, Glogar D.

Radiother Oncol. 2006 Jan;78(1):60-6. Epub 2005 Nov 22.

PMID:
16309769
40.

Transplant coronary artery disease: Incidence, progression and interventional revascularization.

Syeda B, Roedler S, Schukro C, Yahya N, Zuckermann A, Glogar D.

Int J Cardiol. 2005 Oct 10;104(3):269-74.

PMID:
16186055
41.

NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study.

Gyöngyösi M, Khorsand A, Zamini S, Sperker W, Strehblow C, Kastrup J, Jorgensen E, Hesse B, Tägil K, Bøtker HE, Ruzyllo W, Teresiñska A, Dudek D, Hubalewska A, Rück A, Nielsen SS, Graf S, Mundigler G, Novak J, Sochor H, Maurer G, Glogar D, Sylven C.

Circulation. 2005 Aug 30;112(9 Suppl):I157-65.

PMID:
16159809
42.

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.

Kastrup J, Jørgensen E, Rück A, Tägil K, Glogar D, Ruzyllo W, Bøtker HE, Dudek D, Drvota V, Hesse B, Thuesen L, Blomberg P, Gyöngyösi M, Sylvén C; Euroinject One Group.

J Am Coll Cardiol. 2005 Apr 5;45(7):982-8.

43.

Characterization of hibernating myocardium with NOGA electroanatomic endocardial mapping.

Gyöngyösi M, Khorsand A, Sochor H, Sperker W, Strehblow C, Graf S, Binder T, Glogar D.

Am J Cardiol. 2005 Mar 15;95(6):722-8.

PMID:
15757597
44.

Quantification of dose perturbation by plaque in vascular brachytherapy.

Wexberg P, Kirisits C, Berger D, Sulzbacher I, Maurer G, Potter R, Georg D, Glogar D.

Eur J Clin Invest. 2005 Mar;35(3):180-5.

PMID:
15733072
45.

Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication.

Christ G, Nikfardjam M, Huber-Beckmann R, Gottsauner-Wolf M, Glogar D, Binder BR, Wojta J, Huber K.

J Thromb Haemost. 2005 Feb;3(2):233-9.

46.

Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study.

Gyöngyösi M, Domanovits H, Benzer W, Haugk M, Heinisch B, Sodeck G, Hödl R, Gaul G, Bonner G, Wojta J, Laggner A, Glogar D, Huber K; ReoPro-BRIDGING Study Group.

Eur Heart J. 2004 Dec;25(23):2125-33.

PMID:
15571828
47.

Electromechanical properties of perfusion/metabolism mismatch: comparison of nonfluoroscopic electroanatomic mapping with 18F-FDG PET.

Graf S, Gyöngyösi M, Khorsand A, Nekolla SG, Pirich C, Kletter K, Dudczak R, Glogar D, Porenta G, Sochor H.

J Nucl Med. 2004 Oct;45(10):1611-8.

48.

Basic treatment planning parameters for a 90Sr / 90Y source train used in endovascular brachytherapy.

Kirisits C, Berger D, Schmid R, Syeda B, Pokrajac B, Glogar D, Pötter R, Georg D.

Z Med Phys. 2004;14(3):159-67.

PMID:
15462417
49.

Vascular remodeling in atherosclerotic femoral arteries: three-dimensional US analysis.

Gyöngyösi M, Strehblow C, Haumer M, Wexberg P, Sperker W, Lehr S, Glogar D, Pasterkamp G, Minar E.

Radiology. 2004 Nov;233(2):366-75. Epub 2004 Aug 31.

PMID:
15340176
50.

Intracoronary brachytherapy with beta-radiation for the treatment of long diffuse in-stent restenosis.

Schukro C, Syeda B, Schmid R, Stemberger A, Lang I, Derntl M, Neunteufl T, Christ G, Kirisits C, Pokrajac B, Glogar D.

Coron Artery Dis. 2004 Aug;15(5):285-9.

PMID:
15238826

Supplemental Content

Loading ...
Support Center